Fluocinonide

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Fluocinonide
Generic name
FLUOCINONIDE
Manufacturer
Zydus Pharmaceuticals USA Inc.
Product type
HUMAN PRESCRIPTION DRUG
SPL set ID
73315c87-4e55-41ea-883b-23d504c1b10d
SPL ID
bd0eaa0d-0a5b-48a2-bc7e-78b8bde33962
Version
5
Effective date
2022-10-04
Source export date
2026-09-28
Source partition
13
Source file
https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:35:48
Harmonized routes table
Harmonized routes
TOPICAL

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 2 matching rows.

adverse reactions

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Hypertrichosis Maceration of the skin Itching Acneiform eruptions Secondary infection Irritation Hypopigmentation Skin atrophy Dryness Perioral dermatitis Striae Folliculitis Allergic contact dermatitis Miliaria

adverse reactions table

<table ID="ID31" width="100%"><col width="33%"/><col width="34%"/><col width="33%"/><tbody><tr><td align="justify" valign="top">Burning </td><td align="justify" valign="top">Hypertrichosis </td><td align="justify" valign="top">Maceration of the skin </td></tr><tr><td align="justify" valign="top">Itching </td><td align="justify" valign="top">Acneiform eruptions </td><td align="justify" valign="top">Secondary infection </td></tr><tr><td align="justify" valign="top">Irritation </td><td align="justify" valign="top">Hypopigmentation </td><td align="justify" valign="top">Skin atrophy </td></tr><tr><td align="justify" valign="top">Dryness </td><td align="justify" valign="top">Perioral dermatitis </td><td align="justify" valign="top">Striae </td></tr><tr><td align="justify" valign="top">Folliculitis </td><td align="justify" valign="top">Allergic contact dermatitis </td><td align="justify" valign="top">Miliaria </td></tr></tbody></table>

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.